← Back to Search

Procedure

PET/CT Imaging-Guided Ablation for Rapid Heartbeat

Phase < 1
Waitlist Available
Research Sponsored by Mercy Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ischemic or nonischemic cardiomyopathy
Be older than 18 years old
Must not have
General contraindications to VT ablation, e.g., major contraindication to anticoagulation therapy, known presence of left ventricular thrombus, reversible causes of VT or VF
Patient is unable to sign informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights

Summary

This trialwill use imaging to plan a heart procedure, using PET/CT scans merged with cardiac scans to help guide it.

Who is the study for?
This trial is for individuals with a type of heart condition called cardiomyopathy who experience rapid, regular heartbeats known as sustained monomorphic ventricular tachycardia. They must have had at least one episode despite medication or choose not to take such drugs. Excluded are those with recent heart attacks, prior ablation, certain types of VT, inability to consent, pregnancy, and contraindications to imaging or anticoagulation therapy.
What is being tested?
The study tests the use of PET/CT cardiac imaging with a special dye before an ablation procedure for ventricular tachycardia. The goal is to see if merging these scans with other cardiac images helps guide the treatment more accurately by correlating anatomy and physiology.
What are the potential side effects?
Potential side effects may include reactions to the dye used in PET/CT scanning (such as allergic reactions), discomfort from the scan process itself, risks associated with ablation like bleeding or infection at the catheter site, and possible exposure to radiation from imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a heart condition that affects how my heart muscle functions.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have conditions that prevent VT ablation, like blood clot issues.
Select...
I am unable to give my consent for treatment.
Select...
I have ventricular tachycardia originating from the right side of my heart.
Select...
I had a procedure for irregular heartbeats less than 30 days ago.
Select...
My only heart rhythm problem is polymorphic VT or VF.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
correlation between PET data and electroanatomic data

Find a Location

Who is running the clinical trial?

Mercy ResearchLead Sponsor
20 Previous Clinical Trials
1,412 Total Patients Enrolled
Washington University School of MedicineOTHER
1,949 Previous Clinical Trials
2,307,543 Total Patients Enrolled
Biosense Webster, Inc.Industry Sponsor
123 Previous Clinical Trials
36,602 Total Patients Enrolled

Media Library

Cardiac PET/CT Imaging (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT02962076 — Phase < 1
Ventricular Tachycardia Research Study Groups:
Ventricular Tachycardia Clinical Trial 2023: Cardiac PET/CT Imaging Highlights & Side Effects. Trial Name: NCT02962076 — Phase < 1
Cardiac PET/CT Imaging (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02962076 — Phase < 1
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top